Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
VER-01 in Chronic Painful Lumbosacral Radiculopathy
NCT06956014Phase 3Recruiting
- Sponsor
- Vertanical
- Start
- Sep 2026
- Primary completion
- Sep 2028
- Modality
- Allosteric Modulators, Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 3 trial of VER-01 in lumbosacral radiculopathy, sponsored by Vertanical. Started Sep 2026; status: recruiting.
02
Drugs
VER-01
03
Conditions
lumbosacral radiculopathy
Beyond the preview
Go deeper on NCT06956014.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06956014.